INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 138 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $251,000 | -13.4% | 185,871 | 0.0% | 0.00% | – |
| Q3 2016 | $290,000 | +16.9% | 185,871 | -0.4% | 0.00% | – |
| Q2 2016 | $248,000 | -73.2% | 186,575 | +6.0% | 0.00% | -100.0% |
| Q1 2016 | $927,000 | -32.2% | 175,980 | +1.1% | 0.00% | -50.0% |
| Q4 2015 | $1,367,000 | -6.4% | 174,092 | +0.8% | 0.00% | 0.0% |
| Q3 2015 | $1,460,000 | -23.4% | 172,757 | -0.7% | 0.00% | 0.0% |
| Q2 2015 | $1,905,000 | -3.9% | 173,975 | +22.7% | 0.00% | -33.3% |
| Q1 2015 | $1,982,000 | -16.3% | 141,774 | +1.2% | 0.00% | 0.0% |
| Q4 2014 | $2,367,000 | +25.2% | 140,131 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $1,890,000 | +5.4% | 140,853 | +0.0% | 0.00% | +50.0% |
| Q2 2014 | $1,794,000 | +13.6% | 140,791 | +6.0% | 0.00% | 0.0% |
| Q1 2014 | $1,579,000 | -13.4% | 132,780 | +0.6% | 0.00% | -33.3% |
| Q4 2013 | $1,823,000 | -22.4% | 131,993 | -2.1% | 0.00% | -25.0% |
| Q3 2013 | $2,350,000 | +14.8% | 134,826 | +6.6% | 0.00% | 0.0% |
| Q2 2013 | $2,047,000 | – | 126,432 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
| EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
| Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
| Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
| MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
| Bleichroeder LP | 250,000 | $298,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
| Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |